Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRESCENDO compliance study in chronic myeloid leukemia on long-term imatinib
2010-018339-16Phase 4Completed
- Sponsor
- GMIHO mbH
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in chronic myelogenous leukemia (CML), sponsored by GMIHO mbH. Primary endpoints: Primary efficacy endpoint and Compliance before and after intervention. Started Jun 2010; status: completed.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2010-018339-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018339-16.